New Study Provides Evidence of Success in the Development of New Blood Vessels
In a new study reported in the journal Circulation, scientists are describing the first objective evidence that gene therapy successfully helped patients grow new blood vessels and significantly increased blood flow to heart muscle. The study found that the treatment both improved tissue that had suffered from restricted blood supply and rescued areas of the heart that caused pain even when the patient was at rest.
The study, conducted by researchers at Tufts University School of Medicine and St. Elizabeth's Medical Center, was conducted with 13 patients, all of whom had chronic chest pain and had failed balloon angioplasty, coronary bypass surgery, or both. The patients underwent an imaging exam to determine which areas of the heart were deficient in blood supply and a new cardiac mapping test that can distinguish between normal and blood-starved heart tissue. They were then given injections of DNA for a substance called vascular endothelial growth factor, or VEGF, directly into four sites in the heart muscle where blood supply was blocked or compromised.
Imaging and mapping studies were repeated after sixty days. Each test revealed that, on average, the amount of compromised heart tissue was substantially reduced. Post-treatment tests showed that in five patients, an area of heart muscle that was particularly damaged from lack of blood was completely revived. While these test results are promising, it is likely to be years before researchers know whether gene therapy, or angiogenisism, can predictably promote blood-vessel growth and provide a new tool in treating heart disease. For more information visit wvweb.com/news/JournalCirculation.
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.